Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 4 | 0 | −4 |
| Shares | 23.7K | 0 | −23.7K (−100.0%) |
| Value | $5.22K | $0 | −$5.22K (−100.0%) |
New holders (0)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (4)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Goldman Sachs Group Inc | 23,741 | $5.22K |
| Vima LLC | 2 | $2 |
| Barclays PLC | 2 | $0 |
| Sugarloaf Wealth Management, LLC | 1 | $0 |